Ferroptosis: A Novel Anti-tumor Action for Cisplatin.
Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, Dai X, Li Z, Wu G.
Cancer Res Treat · research-article; journal article · DOI 10.4143/crt.2016.572 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för cisplatin. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
11 hitsMechanisms of cisplatin ototoxicity: theoretical review.
Gonçalves MS, Silveira AF, Teixeira AR, Hyppolito MA.
J Laryngol Otol · review; journal article · DOI 10.1017/s0022215113000947Overcoming cisplatin resistance in chemotherapy by biomineralization.
Chen W, Xiao Y, Liu X, Chen Y, Zhang J, Xu X, Tang R.
Chem Commun (Camb) · research support, non-u.s. gov't; journal article · DOI 10.1039/c3cc41872cCisplatin resistance associated with PARP hyperactivation.
Michels J, Vitale I, Galluzzi L, Adam J, Olaussen KA, Kepp O, Senovilla L, Talhaoui I, Guegan J, Enot DP, Talbot M, Robin A, Girard P, Oréar C, Lissa D, Sukkurwala AQ, Garcia P, Behnam-Motlagh P, Kohno K, Wu GS, Brenner C, Dessen P, Saparbaev M, Soria JC, Castedo M, Kroemer G.
Cancer Res · research support, non-u.s. gov't; journal article · DOI 10.1158/0008-5472.can-12-3000Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins.
Mirandola P, Sponzilli I, Gobbi G, Marmiroli S, Rinaldi L, Binazzi R, Piccari GG, Ramazzotti G, Gaboardi GC, Cocco L, Vitale M.
Int J Oncol · research support, non-u.s. gov't; journal article · DOI 10.3892/ijo.28.1.127Enhancing alkylating agent resistance through ERCC2 gene transfection in human glioma cell line.
Chen Z, Zhang J, Mohr G.
Chin Med J (Engl) · comparative study; research support, non-u.s. gov't; journal articleImpairment of the renal p-aminohippurate transport induced by 6-hydroxydopamine.
Cojocel C, Thomson MS.
J Pharm Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1211/002235703765344586Use of cultured cells of kidney origin to assess specific cytotoxic effects of nephrotoxins.
Li W, Choy DF, Lam MS, Morgan T, Sullivan ME, Post JM.
Toxicol In Vitro · journal article · DOI 10.1016/s0887-2333(02)00128-5Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent.
Pujol JL, Carestia L, Daurès JP.
Br J Cancer · meta-analysis; comparative study; research-article; journal article · DOI 10.1054/bjoc.2000.1164On the Mechanism of Action of the Antitumor Drug cis-Platin (cis-DDP) and its Second Generation Derivatives.
Aletras V, Hadjiliadis D, Hadjiliadis N.
Met Based Drugs · research-article; journal article · DOI 10.1155/mbd.1995.153Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.
Terheggen PM, Floot BG, Lempers EL, van Tellingen O, Begg AC, den Engelse L.
Cancer Chemother Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/bf00685507